MHP
NVAX icon

Manatuck Hill Partners’s Novavax NVAX Stock Holding History

Manatuck Hill Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-25,000
Closed -$1.57M – 100
2013
Q3 		$1.57M Buy
+25,000
New +$1.41M 0.2% 68

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Manatuck Hill Partners's NVAX Position: Q4 2013 in Review

Manatuck Hill Partners sold out of Novavax (NVAX) in Q4 2013, closing a stake of 25,000 shares — an estimated $1.57M sold.

Manatuck Hill Partners first reported a position in NVAX in Q3 2013 and held it in 1 quarter. The position peaked at $1.57M in Q3 2013. 129 funds tracked by Wall St. Rank hold NVAX as of Q4 2013.

  • Manatuck Hill Partners reported no remaining Novavax position as of Q4 2013 after selling out during the quarter.
  • Manatuck Hill Partners sold 25,000 Novavax shares in Q4 2013, an estimated $1.57M.
  • Manatuck Hill Partners first reported a position in Novavax in Q3 2013 and held it in 1 quarter.
  • Manatuck Hill Partners's Novavax position peaked at $1.57M in Q3 2013.
  • 129 funds tracked by Wall St. Rank held Novavax as of Q4 2013.

Based on Manatuck Hill Partners's 13F filing for Q4 2013, filed 14 Feb 2014.